2, 0.5 and 1 M NaCl; lanes 12-14: complex treated with 0, 0.5 and 1 M NaCl at pH 12. (TIFF 5 MB) Additional file 4: Figure S4: DNA precipitation from diluted systems. On agarose gel: 1. pUC19/EcoRI (100 ng); 2. pUC19/EcoRI purified with GeneJet PCR purification Kit (Fermentas); 3. 100 ng of pUC19/EcoRI diluted 1.5 × 10-4 in 15 mL buffer and salvaged with Imu3 precipitation and subsequent GeneJet PCR purification Kit Imu3 removal. (TIFF 3 MB) References 1. Ostblom A, Adlerberth I, Wold AE, Nowrouzian FL: Pathogenicity island markers, virulence determinants malx and usp, and the capacity of Escherichia coli

to persist in infants’ commensal microbiotas. Appl Environ Microbiol 2011,77(7):2303–2308.PubMedCentralPubMedCrossRef 2. Bauer RJ, Zhang LX, Foxman B, Siitonen A, Jantunen SYN-117 chemical structure ME, Saxen H, Marrs CF: Molecular epidemiology Acalabrutinib nmr of 3 putative virulence genes for Escherichia coli urinary tract infection – usp, iha, and iroN(E-coli). J Infect Dis 2002,185(10):1521–1524.PubMedCrossRef 3. Kanamaru S, Kurazono H, Ishitoya S, Terai A, Habuchi T, Nakano M, Ogawa O, Yamamoto S: Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 2003,170(6):2490–2493.PubMedCrossRef 4. Kurazono H, Yamamoto S, Nakano M, Nair GB, Terai A, Chaicumpa W, Hayashi

H: Characterization of a putative virulence island in the chromosome of uropathogenic Escherichia coli possessing a gene encoding a uropathogenic-specific protein. Microb Pathog 2000,28(3):183–189.PubMedCrossRef 5. Parret AHA, De Mot R: Escherichia coli’s uropathogenic-specific protein: a bacteriocin promoting infectivity? Microbiol-Sgm 2002, 148:1604–1606. 6. Nakano M, Yamamoto S, Terai A, Ogawa O, Makino S, Hayashi H, Nair GB, Kurazono H: Structural and sequence diversity

of the pathogenicity Histone demethylase island of uropathogenic Escherichia coli which encodes the USP protein. FEMS Microbiol Lett 2001,205(1):71–76.PubMedCrossRef 7. Papadakos G, Wojdyla JA, Kleanthous C: Nuclease colicins and their immunity proteins. Q Rev Biophys 2012,45(1):57–103.PubMedCrossRef 8. Nipič D, Podlesek Z, Črnigoj M, BudiČ M, Žgur-Bertok D: The Escherichia coli uropathogenic specific protein Usp, is a bacteriocin-like genotoxin. J Infect Dis 2013. In press 9. Cascales E, Gilteritinib manufacturer Buchanan SK, Duche D, Kleanthous C, Lloubes R, Postle K, Riley M, Slatin S, Cavard D: Colicin biology. Microbiol Mol Biol Rev 2007,71(1):158–229.PubMedCentralPubMedCrossRef 10. Wallis R, Leung KY, Pommer AJ, Videler H, Moore GR, James R, Kleanthous C: Protein-protein interactions in colicin E9 DNase-immunity protein complexes .2. Cognate and noncognate interactions that span the millimolar to femtomolar affinity range. Biochemistry 1995,34(42):13751–13759.PubMedCrossRef 11. Ko TP, Liao CC, Ku WY, Chak KF, Yuan HS: The crystal structure of the DNase domain of colicin E7 in complex with its inhibitor Im7 protein.